Pharmaceuticals, Biotechnology and Life Sciences
CUE-401, a first-in-class bispecific molecule designed to induce and expand Tregs in vivo through the co-activity of transforming TGF-β and…
GAITHERSBURG, Md., June 24, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a…
CARSON CITY, Nev., June 24, 2025 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company…
NORWOOD, Mass., June 24, 2025 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced…
– PDUFA action date set for October 25, 2025 – – sNDA being reviewed under FDA’s RTOR program – – Revumenib…
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) — Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent…
Aggregated presentation by day and by market Statement of transactions in own shares…
REDMOND, Wash., June 24, 2025 (GLOBE NEWSWIRE) — Inventprise, a clinical stage vaccine invention company, today announced the publication of…
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated…
Revolutionary Canine Supplement Promotes Regenerative Healing Through Stem Cell ActivationLAS VEGAS , June 24, 2025 (GLOBE NEWSWIRE) — via IBN…